IRIDEX CORPORATION (NASDAQ:IRIX) Files An 8-K Financial Statements and Exhibits
Item 9.01.
Financial Statements and Exhibits.
|
Exhibit No. |
Description |
|
99.1 |
Press Release dated February 12, 2019. |
IRIDEX CORP Exhibit
EX-99.1 2 irix-ex991_7.htm EX-99.1 irix-ex991_7.htm Exhibit 99.1 IRIDEX Announces Resolution of its Dispute with Quantel Medical Mountain View,…
To view the full exhibit click here
About IRIDEX CORPORATION (NASDAQ:IRIX)
IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company’s ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.
